Name two nonbenzodiazepine sleep aids and a key safety concern.

Name two nonbenzodiazepine sleep aids and a key safety concern.

• A. Zolpidem and Eszopiclone; concerns include complex sleep behaviors, dependence, and next-day impairment
• B. Zaleplon and Suvorexant; concerns include severe liver toxicity
• C. Diphenhydramine and Doxylamine; concerns include no sleep induction
• D. Ramelteon and Tasimelteon; concerns include severe respiratory depression

Answer: (A)

Nonbenzodiazepine sleep aids like zolpidem and eszopiclone work by modulating GABA activity to help you fall asleep and stay asleep, often with fewer muscle-relaxant effects than benzodiazepines. The key safety concerns with these drugs are real and clinically important: complex sleep behaviors, where a person may perform activities (such as walking, driving, cooking) while not fully awake and may not remember them afterward; the potential for dependence or tolerance with longer use, leading to withdrawal or need for higher doses; and next-day impairment, including drowsiness and slowed reaction time that can affect driving or concentration. These risks make zolpidem and eszopiclone a classic pairing for nonbenzodiazepine sleep aids with these safety considerations.

Nonbenzodiazepine sleep aids like zolpidem and eszopiclone work by modulating GABA activity to help you fall asleep and stay asleep, often with fewer muscle-relaxant effects than benzodiazepines. The key safety concerns with these drugs are real and clinically important: complex sleep behaviors, where a person may perform activities (such as walking, driving, cooking) while not fully awake and may not remember them afterward; the potential for dependence or tolerance with longer use, leading to withdrawal or need for higher doses; and next-day impairment, including drowsiness and slowed reaction time that can affect driving or concentration. These risks make zolpidem and eszopiclone a classic pairing for nonbenzodiazepine sleep aids with these safety considerations.